Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine
Sumito Ito, Hiroyuki Kusuhara, Yushun Kuroiwa, Chunyong Wu, Yoshinori Moriyama, Katsuhisa Inoue, Tsunenori Kondo, Hiroaki Yuasa, Hideki Nakayama, Shigeru Horita and Yuichi Sugiyama
Journal of Pharmacology and Experimental Therapeutics January 11, 2010, jpet.109.163642; DOI: https://doi.org/10.1124/jpet.109.163642
Sumito Ito
Hiroyuki Kusuhara
Yushun Kuroiwa
Chunyong Wu
Yoshinori Moriyama
Katsuhisa Inoue
Tsunenori Kondo
Hiroaki Yuasa
Hideki Nakayama
Shigeru Horita
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine
Sumito Ito, Hiroyuki Kusuhara, Yushun Kuroiwa, Chunyong Wu, Yoshinori Moriyama, Katsuhisa Inoue, Tsunenori Kondo, Hiroaki Yuasa, Hideki Nakayama, Shigeru Horita and Yuichi Sugiyama
Journal of Pharmacology and Experimental Therapeutics January 11, 2010, jpet.109.163642; DOI: https://doi.org/10.1124/jpet.109.163642
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine
Sumito Ito, Hiroyuki Kusuhara, Yushun Kuroiwa, Chunyong Wu, Yoshinori Moriyama, Katsuhisa Inoue, Tsunenori Kondo, Hiroaki Yuasa, Hideki Nakayama, Shigeru Horita and Yuichi Sugiyama
Journal of Pharmacology and Experimental Therapeutics January 11, 2010, jpet.109.163642; DOI: https://doi.org/10.1124/jpet.109.163642
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement